Protecting Intellectual Property
Before you publish, consider whether your results are an invention that might benefit patients. Journal publications, website publications, and presentations at conferences constitute public disclosure of intellectual property. Once the invention has been publicly disclosed, a patent usually cannot be obtained.
Questions – Contact Mount Sinai Innovation Partners (MSIP)
Consolidated Standards of Reporting Trials (CONSORT)
Consolidated Standards of Reporting Trials (CONSORT) – documents and resources to facilitate reporting of randomized trials
Requirements for Acknowledging NIH-Supported Research
Acknowledging ISMMS ConduITS CTSA Support - NIH Requirement
The NIH requires publications, posters, grants arising from research projects receiving support from the ConduITS CTSA to acknowledge grant support.
This is applicable to all faculty and research staff within the MSHS who have received ConduITS support (including consultations, training, workshops, funding) through the use of the following ConduITS resources and services:
- Biostatistics, Epidemiology & Research Design (BERD)
- ConduITS Community Engagement
- Biobanking Resources
- LabVantage Biorepository Management System
- Biospecimen storage
- International Center for Health Outcomes and Innovation Research (InCHOIR)
- Office of Research Services (ORS)
- Clinical Trials.gov
- Investigational New Drug (IND)/ Investigational Device Exemption Consults
- Pre-Protocol Development Consults
- Recruitment Consult
- EPIC Participant Recruitment for Clinical Research
- ResearchMatch Consults and Support
- Research Information Technology
- Mount Sinai Data Warehouse (MSDW)
- Career Development Funding
- KL2 Scholars
- TL1 Scholars
- Pilot Programs Funding
- 4D technology development pilot projects
Include this recommended language in your publication:
“Supported by grant UL1TR001433 from the National Center for Advancing Translational Sciences, National Institutes of Health.”
Not sure if you should acknowledge the CTSA, ask here: Research 411 ticket.
NIH Public Access Policy
The National Institutes of Health (NIH) Public Access Policy requires that all investigators funded by the NIH, upon acceptance for publication, must submit an electronic version of their final peer-reviewed manuscripts to National Library of Medicine’s PubMed Central.
The NIH Public Access Policy applies to any manuscript that:
- Is peer-reviewed
- And, is accepted for publication in a journal on or after April 7, 2008
- And, arises from:
- Any direct funding from an NIH grant or cooperative agreement active in Fiscal Year 2008 or beyond, or;
- Any direct funding from an NIH contract signed on or after April 7, 2008, or;
- Any direct funding from the NIH Intramural Program, or;
- An NIH employee.
In 2013, the NIH established New Compliance Requirements whereby NIH will delay processing of non-competing continuation awards if publications arising from that award are not in compliance with the NIH Public Access Policy.
Compliance is being tracked through Research Performance Progress Reports (RPPRs). These interface with the My Bibliography feature of My NCBI to alert researchers and authors of non-compliant publications.
Manuscripts must be submitted to PubMed Central no later than 12 months after the official date of publication.
Refer to the detailed instructions for submitting to PubMed Central.
Research 411 Portal
Still Need Help?
Research Roadmap Feedback
Please provide feedback about your experience on this website.